{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:37:22Z","timestamp":1792737442823,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]},{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]},{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]},{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]},{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]},{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]},{"name":"the National Key Research and Development Program of China","award":["NO.2022YFC2406900"],"award-info":[{"award-number":["NO.2022YFC2406900"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-026-02069-0","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:27:24Z","timestamp":1787621244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal PET Imaging Unveils Early Metabolic Compensation Mechanisms and Dopaminergic Degeneration in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Zhao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Zhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-3921","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"2069_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20:385\u201397. https:\/\/doi.org\/10.1016\/s1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"key":"2069_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK. Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91:795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2069_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/s1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257\u201372. https:\/\/doi.org\/10.1016\/s1474-4422(16)30230-7.","journal-title":"Lancet Neurol"},{"key":"2069_CR4","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/s0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR. Parkinson\u2019s disease. Lancet. 2004;363:1783\u201393. https:\/\/doi.org\/10.1016\/s0140-6736(04)16305-8.","journal-title":"Lancet"},{"key":"2069_CR5","doi-asserted-by":"crossref","unstructured":"Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2006:5.","DOI":"10.1016\/S1474-4422(05)70285-4"},{"key":"2069_CR6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/jnnp-2023-331170","volume":"94","author":"SH Jeong","year":"2023","unstructured":"Jeong SH, Park CJ, Jeong HJ, Sunwoo MK, Ahn SS, Lee SK, et al. Association of choroid plexus volume with motor symptoms and dopaminergic degeneration in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2023;94:1047\u201355. https:\/\/doi.org\/10.1136\/jnnp-2023-331170.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2069_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323:548\u201360. https:\/\/doi.org\/10.1001\/jama.2019.22360.","journal-title":"JAMA"},{"key":"2069_CR8","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1007\/s00259-021-05325-z","volume":"48","author":"X Hu","year":"2021","unstructured":"Hu X, Sun X, Hu F, Liu F, Ruan W, Wu T, et al. Multivariate radiomics models based on (18)F-FDG hybrid PET\/MRI for distinguishing between Parkinson\u2019s disease and multiple system atrophy. Eur J Nucl Med Mol Imaging. 2021;48:3469\u201381. https:\/\/doi.org\/10.1007\/s00259-021-05325-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00392-x","volume":"8","author":"N Schr\u00f6ter","year":"2022","unstructured":"Schr\u00f6ter N, Blazhenets G, Frings L, Jost WH, Weiller C, Rijntjes M, et al. Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes. NPJ Parkinsons Dis. 2022;8:123. https:\/\/doi.org\/10.1038\/s41531-022-00392-x.","journal-title":"NPJ Parkinsons Dis"},{"key":"2069_CR10","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer PT, Frings L, R\u00fccker G, Hellwig S. (18)F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med. 2017;58:1888\u201398. https:\/\/doi.org\/10.2967\/jnumed.116.186403.","journal-title":"J Nucl Med"},{"key":"2069_CR11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00259-018-4031-2","volume":"45","author":"Z Walker","year":"2018","unstructured":"Walker Z, Gandolfo F, Orini S, Garibotto V, Agosta F, Arbizu J, et al. Clinical utility of FDG PET in Parkinson\u2019s disease and atypical parkinsonism associated with dementia. Eur J Nucl Med Mol Imaging. 2018;45:1534\u201345. https:\/\/doi.org\/10.1007\/s00259-018-4031-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR12","doi-asserted-by":"publisher","first-page":"e2314","DOI":"10.1212\/wnl.0000000000207748","volume":"101","author":"LC Beauchamp","year":"2023","unstructured":"Beauchamp LC, Dore V, Villemagne VL, Xu S, Finkelstein D, Barnham KJ, et al. Using (18)F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease. Neurology. 2023;101:e2314\u201324. https:\/\/doi.org\/10.1212\/wnl.0000000000207748.","journal-title":"Neurology"},{"key":"2069_CR13","doi-asserted-by":"publisher","first-page":"931015","DOI":"10.3389\/fnagi.2022.931015","volume":"14","author":"XL Liu","year":"2022","unstructured":"Liu XL, Liu SY, Barret O, Tamagnan GD, Qiao HW, Song TB, et al. Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson\u2019s disease. Front Aging Neurosci. 2022;14:931015. https:\/\/doi.org\/10.3389\/fnagi.2022.931015.","journal-title":"Front Aging Neurosci"},{"key":"2069_CR14","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1016\/j.acra.2024.08.016","volume":"31","author":"T Zhao","year":"2024","unstructured":"Zhao T, Wang B, Liang W, Cheng S, Wang B, Cui M, et al. Accuracy of (18)F-FDG PET imaging in differentiating Parkinson\u2019s disease from atypical parkinsonian syndromes: a systematic review and meta-analysis. Acad Radiol. 2024;31:4575\u201394. https:\/\/doi.org\/10.1016\/j.acra.2024.08.016.","journal-title":"Acad Radiol"},{"key":"2069_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s00330-023-10003-9","volume":"34","author":"J Sun","year":"2024","unstructured":"Sun J, Cong C, Li X, Zhou W, Xia R, Liu H, et al. Identification of Parkinson\u2019s disease and multiple system atrophy using multimodal PET\/MRI radiomics. Eur Radiol. 2024;34:662\u201372. https:\/\/doi.org\/10.1007\/s00330-023-10003-9.","journal-title":"Eur Radiol"},{"key":"2069_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.902169","volume":"14","author":"Y Pan","year":"2022","unstructured":"Pan Y, Liu S, Zeng Y, Ye C, Qiao H, Song T, et al. A multi-atlas-based [18F]9-fluoropropyl-(+)-dihydrotetrabenazine positron emission tomography image segmentation method for Parkinson\u2019s disease quantification. Front Aging Neurosci. 2022;14:902169. https:\/\/doi.org\/10.3389\/fnagi.2022.902169.","journal-title":"Front Aging Neurosci"},{"key":"2069_CR17","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.21037\/qims-24-804","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Lu W, Yan S, Song T, Zhang C, Yang C, et al. The combination of (18)F-fluorodeoxyglucose and (18)F 9-fluoropropyl-(+)-dihydrotetrabenazine positron emission tomography for distinguishing between early-onset and late-onset idiopathic Parkinson disease and analyzing influencing factors. Quant Imaging Med Surg. 2024;14:7406\u201319. https:\/\/doi.org\/10.21037\/qims-24-804.","journal-title":"Quant Imaging Med Surg"},{"key":"2069_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00259-019-04570-7","volume":"47","author":"SK Meles","year":"2020","unstructured":"Meles SK, Renken RJ, Pagani M, Teune LK, Arnaldi D, Morbelli S, et al. Abnormal pattern of brain glucose metabolism in Parkinson\u2019s disease: replication in three European cohorts. Eur J Nucl Med Mol Imaging. 2020;47:437\u201350. https:\/\/doi.org\/10.1007\/s00259-019-04570-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/rlu.0000000000002148","volume":"43","author":"FT Liu","year":"2018","unstructured":"Liu FT, Ge JJ, Wu JJ, Wu P, Ma Y, Zuo CT, et al. Clinical, dopaminergic, and metabolic correlations in Parkinson disease: a dual-tracer PET study. Clin Nucl Med. 2018;43:562\u201371. https:\/\/doi.org\/10.1097\/rlu.0000000000002148.","journal-title":"Clin Nucl Med"},{"key":"2069_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2967\/jnumed.113.121897","volume":"55","author":"SC Lin","year":"2014","unstructured":"Lin SC, Lin KJ, Hsiao IT, Hsieh CJ, Lin WY, Lu CS, et al. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET. J Nucl Med. 2014;55:73\u20139. https:\/\/doi.org\/10.2967\/jnumed.113.121897.","journal-title":"J Nucl Med"},{"key":"2069_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1180541","volume":"10","author":"Y Hong","year":"2023","unstructured":"Hong Y, Fu C, Xing Y, Tao J, Zhao T, Wang N, et al. Delayed (18)F-FDG PET imaging provides better metabolic asymmetry in potential epileptogenic zone in temporal lobe epilepsy. Front Med. 2023;10:1180541. https:\/\/doi.org\/10.3389\/fmed.2023.1180541.","journal-title":"Front Med"},{"key":"2069_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103555","volume":"41","author":"X Shi","year":"2024","unstructured":"Shi X, Gu Q, Fu C, Ma J, Li D, Zheng J, et al. Relationship of irisin with disease severity and dopamine uptake in Parkinson\u2019s disease patients. Neuroimage Clin. 2024;41:103555. https:\/\/doi.org\/10.1016\/j.nicl.2023.103555.","journal-title":"Neuroimage Clin"},{"key":"2069_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2967\/jnumed.108.061572","volume":"50","author":"P Jokinen","year":"2009","unstructured":"Jokinen P, Helenius H, Rauhala E, Br\u00fcck A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med. 2009;50:893\u20139. https:\/\/doi.org\/10.2967\/jnumed.108.061572.","journal-title":"J Nucl Med"},{"key":"2069_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","volume":"71","author":"IT Hsiao","year":"2014","unstructured":"Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, et al. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA Neurol. 2014;71:758\u201366. https:\/\/doi.org\/10.1001\/jamaneurol.2014.290.","journal-title":"JAMA Neurol"},{"key":"2069_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00341-8","volume":"8","author":"K Steidel","year":"2022","unstructured":"Steidel K, Ruppert MC, Greuel A, Tahmasian M, Maier F, Hammes J, et al. Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson\u2019s disease. NPJ Park Dis. 2022;8:79. https:\/\/doi.org\/10.1038\/s41531-022-00341-8.","journal-title":"NPJ Park Dis"},{"key":"2069_CR26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/brain\/awaa019","volume":"143","author":"MC Ruppert","year":"2020","unstructured":"Ruppert MC, Greuel A, Tahmasian M, Schwartz F, St\u00fcrmer S, Maier F, et al. Network degeneration in Parkinson\u2019s disease: multimodal imaging of nigro-striato-cortical dysfunction. Brain. 2020;143:944\u201359. https:\/\/doi.org\/10.1093\/brain\/awaa019.","journal-title":"Brain"},{"key":"2069_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.627356","volume":"13","author":"L Han","year":"2021","unstructured":"Han L, Lu J, Tang Y, Fan Y, Chen Q, Li L, et al. Dopaminergic and metabolic correlations with cognitive domains in non-demented Parkinson\u2019s disease. Front Aging Neurosci. 2021;13:627356. https:\/\/doi.org\/10.3389\/fnagi.2021.627356.","journal-title":"Front Aging Neurosci"},{"key":"2069_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07070-z","author":"J Silva-Rodr\u00edguez","year":"2025","unstructured":"Silva-Rodr\u00edguez J, Labrador-Espinosa M, Castro-Labrador S, Mu\u00f1oz-Delgado L, Franco-Rosado P, Castellano-Guerrero AM, et al. Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07070-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR29","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s13311-022-01199-7","volume":"19","author":"S Nuber","year":"2022","unstructured":"Nuber S, Chung CY, Tardiff DF, Bechade PA, McCaffery TD, Shimanaka K, et al. A brain-penetrant stearoyl-CoA desaturase inhibitor reverses \u03b1-synuclein toxicity. Neurotherapeutics. 2022;19:1018\u201336. https:\/\/doi.org\/10.1007\/s13311-022-01199-7.","journal-title":"Neurotherapeutics"},{"key":"2069_CR30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.brs.2012.12.004","volume":"6","author":"F Carrillo","year":"2013","unstructured":"Carrillo F, Palomar FJ, Conde V, Diaz-Corrales FJ, Porcacchia P, Fern\u00e1ndez-Del-Olmo M, et al. Study of cerebello-thalamocortical pathway by transcranial magnetic stimulation in Parkinson\u2019s disease. Brain Stimul. 2013;6:582\u20139. https:\/\/doi.org\/10.1016\/j.brs.2012.12.004.","journal-title":"Brain Stimul"},{"key":"2069_CR31","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1089\/neu.2023.0429","volume":"41","author":"G Terry","year":"2024","unstructured":"Terry G, Pagulayan KF, Muzi M, Mayer C, Murray DR, Schindler AG, et al. Increased [(18)F]fluorodeoxyglucose uptake in the left pallidum in military veterans with blast-related mild traumatic brain injury: potential as an imaging biomarker and mediation with executive dysfunction and cognitive impairment. J Neurotrauma. 2024;41:1578\u201396. https:\/\/doi.org\/10.1089\/neu.2023.0429.","journal-title":"J Neurotrauma"},{"key":"2069_CR32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/mdc3.14191","volume":"11","author":"N Vijiaratnam","year":"2024","unstructured":"Vijiaratnam N, Girges C, Athauda D, King A, Auld G, McComish R, et al. Exploring analysis approaches for using the dopamine transporter striatal binding ratio in early- to mid-stage Parkinson\u2019s disease modification trials. Mov Disord Clin Pract. 2024;11:1345\u201354. https:\/\/doi.org\/10.1002\/mdc3.14191.","journal-title":"Mov Disord Clin Pract"},{"key":"2069_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103246","volume":"36","author":"JF Fu","year":"2022","unstructured":"Fu JF, Wegener T, Klyuzhin IS, Mannheim JG, McKeown MJ, Stoessl AJ, et al. Spatiotemporal patterns of putaminal dopamine processing in Parkinson\u2019s disease: a multi-tracer positron emission tomography study. Neuroimage Clin. 2022;36:103246. https:\/\/doi.org\/10.1016\/j.nicl.2022.103246.","journal-title":"Neuroimage Clin"},{"key":"2069_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00259-023-06403-0","volume":"51","author":"M Tian","year":"2024","unstructured":"Tian M, Zuo C, Cahid Civelek A, Carrio I, Watanabe Y, Kang KW, et al. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism. Eur J Nucl Med Mol Imaging. 2024;51:434\u201342. https:\/\/doi.org\/10.1007\/s00259-023-06403-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2069_CR35","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209453","volume":"102","author":"A Hastings","year":"2024","unstructured":"Hastings A, Cullinane P, Wrigley S, Revesz T, Morris HR, Dickson JC, et al. Neuropathologic validation and diagnostic accuracy of presynaptic dopaminergic imaging in the diagnosis of parkinsonism. Neurology. 2024;102:e209453. https:\/\/doi.org\/10.1212\/wnl.0000000000209453.","journal-title":"Neurology"},{"key":"2069_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","volume":"32","author":"D Eidelberg","year":"2009","unstructured":"Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009;32:548\u201357. https:\/\/doi.org\/10.1016\/j.tins.2009.06.003.","journal-title":"Trends Neurosci"},{"key":"2069_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s41181-024-00301-y","volume":"9","author":"R Zhao","year":"2024","unstructured":"Zhao R, Chen J, Ye T, Chu J, Li J, Zhang Y, et al. First-in-human study of D6-[(18)F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [(18)F]FP-(+)-DTBZ (AV-133). EJNMMI radiopharmacy Chem. 2024;9:71. https:\/\/doi.org\/10.1186\/s41181-024-00301-y.","journal-title":"EJNMMI radiopharmacy Chem"},{"key":"2069_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00415-025-12932-5","volume":"272","author":"J Pasquini","year":"2025","unstructured":"Pasquini J, Sigurdsson HP, Firbank M, Best L, Foster V, Galley D, et al. Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy. J Neurol. 2025;272:195. https:\/\/doi.org\/10.1007\/s00415-025-12932-5.","journal-title":"J Neurol"},{"key":"2069_CR39","doi-asserted-by":"publisher","first-page":"e210105","DOI":"10.1212\/wnl.0000000000210105","volume":"103","author":"HS Yoo","year":"2024","unstructured":"Yoo HS, Kim HK, Na HK, Kang S, Park M, Ahn SJ, et al. Association of Striatal Dopamine Depletion and Brain Metabolism Changes With Motor and Cognitive Deficits in Patients With Parkinson Disease. Neurology. 2024;103:e210105. https:\/\/doi.org\/10.1212\/wnl.0000000000210105.","journal-title":"Neurology"},{"key":"2069_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.adp3645","volume":"387","author":"KM Wu","year":"2025","unstructured":"Wu KM, Xu QH, Liu YQ, Feng YW, Han SD, Zhang YR, et al. Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson\u2019s disease. Sci (New York NY). 2025;387:892\u2013900. https:\/\/doi.org\/10.1126\/science.adp3645.","journal-title":"Sci (New York NY)"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02069-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-02069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:37:28Z","timestamp":1792733848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-02069-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2069"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-02069-0","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and received approval from the Medical Research Ethics Committee of Xuanwu Hospital, Capital Medical University (No. [2023]044).","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}